chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Arm swollen after 2nd dose; Arm sore after 2nd dose; Couldn't sleep after 2nd dose; Eyes felt like sandpaper after 2nd dose; Felt like there was a light on in brain after 2nd dose; Upper body aches after 2nd dose; Fatigue after 2nd dose; Low grade fever after 2nd dose; Chills after 2nd dose; Low scale headache after 2nd dose; Queasy after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm swollen after 2nd dose), PAIN IN EXTREMITY (Arm sore after 2nd dose), INSOMNIA (Couldn't sleep after 2nd dose), ABNORMAL SENSATION IN EYE (Eyes felt like sandpaper after 2nd dose) and BLOOD PRESSURE DECREASED (Felt like there was a light on in brain after 2nd dose) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022m20a and 046a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Arm swollen after 2nd dose), PAIN IN EXTREMITY (Arm sore after 2nd dose), INSOMNIA (Couldn't sleep after 2nd dose), ABNORMAL SENSATION IN EYE (Eyes felt like sandpaper after 2nd dose), BLOOD PRESSURE DECREASED (Felt like there was a light on in brain after 2nd dose), PAIN (Upper body aches after 2nd dose), FATIGUE (Fatigue after 2nd dose), PYREXIA (Low grade fever after 2nd dose), CHILLS (Chills after 2nd dose), HEADACHE (Low scale headache after 2nd dose) and NAUSEA (Queasy after 2nd dose). At the time of the report, PERIPHERAL SWELLING (Arm swollen after 2nd dose), PAIN IN EXTREMITY (Arm sore after 2nd dose), INSOMNIA (Couldn't sleep after 2nd dose), ABNORMAL SENSATION IN EYE (Eyes felt like sandpaper after 2nd dose), BLOOD PRESSURE DECREASED (Felt like there was a light on in brain after 2nd dose), PAIN (Upper body aches after 2nd dose), FATIGUE (Fatigue after 2nd dose), PYREXIA (Low grade fever after 2nd dose), CHILLS (Chills after 2nd dose), HEADACHE (Low scale headache after 2nd dose) and NAUSEA (Queasy after 2nd dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Knot on the back of her head; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Knot on the back of her head) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008b21a) for COVID-19 vaccination.     Concomitant products included IMMUNOSUPPRESSANTS and IMMUNOGLOBULIN HUMAN NORMAL (PRIVIGEN) for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced SWELLING (Knot on the back of her head). At the time of the report, SWELLING (Knot on the back of her head) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: follow-up was received on 11-may-2021, contain no significant information
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Headache, Myalgia, Pyrexia
Clinical narrative: no appetite; Severe body aches; fever not very high; headache; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (no appetite), MYALGIA (Severe body aches), PYREXIA (fever not very high) and HEADACHE (headache) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019821A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced DECREASED APPETITE (no appetite), MYALGIA (Severe body aches), PYREXIA (fever not very high) and HEADACHE (headache). At the time of the report, DECREASED APPETITE (no appetite), MYALGIA (Severe body aches), PYREXIA (fever not very high) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product was not provided by the reporter. Treatment information was not provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Limb discomfort, Lip swelling, Swollen tongue
Clinical narrative: swelling of lower lip; numbness of the lower lip; swelling of tongue; numbness of the tongue; Heaviness of the right leg; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (swelling of lower lip), HYPOAESTHESIA ORAL (numbness of the lower lip), SWOLLEN TONGUE (swelling of tongue), HYPOAESTHESIA ORAL (numbness of the tongue) and LIMB DISCOMFORT (Heaviness of the right leg) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 immunisation.     The patient's past medical history included Kidney transplant. Concurrent medical conditions included Drug allergy (Allergic to lisinopril, Haldol). Concomitant products included VALPROATE SEMISODIUM (DEPAKOTE), ARIPIPRAZOLE (ABILIFY), HYDRALAZINE, CALCIUM CARBONATE, GRAMICIDIN, NEOMYCIN SULFATE, NYSTATIN, TRIAMCINOLONE ACETONIDE (KENALOG COMP. MED MYCOSTATIN), MYCOPHENOLATE MOFETIL HYDROCHLORIDE (CELLCEPT [MYCOPHENOLATE MOFETIL HYDROCHLORIDE]), FAMOTIDINE (PEPCID AC), PREDNISONE, BELATACEPT (NULOJIX), TRAMADOL, SODIUM BICARBONATE, CALCITRIOL (ROCALTROL), CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), PARACETAMOL (TYLENOL), DOCUSATE SODIUM, SENNOSIDE A+B (SENOKOT S) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced LIP SWELLING (swelling of lower lip), HYPOAESTHESIA ORAL (numbness of the lower lip), SWOLLEN TONGUE (swelling of tongue), HYPOAESTHESIA ORAL (numbness of the tongue) and LIMB DISCOMFORT (Heaviness of the right leg). At the time of the report, LIP SWELLING (swelling of lower lip), HYPOAESTHESIA ORAL (numbness of the lower lip), SWOLLEN TONGUE (swelling of tongue), HYPOAESTHESIA ORAL (numbness of the tongue) and LIMB DISCOMFORT (Heaviness of the right leg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was provided by the reporter as immunosuppressants, fibroid pills. Treatment information was provided as paracetamol.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (BAYER ASPIRIN), CITALOPRAM and OMEPRAZOLE for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of 1 dosage form. At the time of the report, PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Heart rate abnormal
Clinical narrative: Heart pounded hard that almost shook her whole body; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events heart pounded hard that almost shook her whole body / heart rate abnormal.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On an unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection.  On 26 Mar 2021, the patient experienced the event, heart pounded hard that almost shook her whole body.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event, heart pounded hard that almost shook her whole body was unknown.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Discomfort, Dizziness, Dry mouth, Dysphonia
Clinical narrative: Stronger pain throughout my body; Cold voice; Loose stools; It's like I'm going to catch the flu; My head hurts too much; General discomfort in the body; Headache; Dizziness; Dry mouth; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), DRY MOUTH (Dry mouth), DISCOMFORT (General discomfort in the body), PAIN (Stronger pain throughout my body) and DYSPHONIA (Cold voice) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced DIZZINESS (Dizziness) and DRY MOUTH (Dry mouth). On 27-Mar-2021, the patient experienced DISCOMFORT (General discomfort in the body) and HEADACHE (Headache). On 28-Mar-2021, the patient experienced PAIN (Stronger pain throughout my body), DYSPHONIA (Cold voice), DIARRHOEA (Loose stools), INFLUENZA LIKE ILLNESS (It's like I'm going to catch the flu) and HEADACHE (My head hurts too much). The patient was treated with ACETAMINOPHEN on 26-Mar-2021 at a dose of UNK dosage form. On 26-Mar-2021, DIZZINESS (Dizziness) had resolved. At the time of the report, DRY MOUTH (Dry mouth), DISCOMFORT (General discomfort in the body), PAIN (Stronger pain throughout my body), DYSPHONIA (Cold voice), DIARRHOEA (Loose stools), INFLUENZA LIKE ILLNESS (It's like I'm going to catch the flu), HEADACHE (Headache) and HEADACHE (My head hurts too much) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Pain
Clinical narrative: Stronger pain throughout my body; Cold voice; Loose stools; It's like I'm going to catch the flu; My head hurts too much; General discomfort in the body; Headache; Dizziness; Dry mouth; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), DRY MOUTH (Dry mouth), DISCOMFORT (General discomfort in the body), PAIN (Stronger pain throughout my body) and DYSPHONIA (Cold voice) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced DIZZINESS (Dizziness) and DRY MOUTH (Dry mouth). On 27-Mar-2021, the patient experienced DISCOMFORT (General discomfort in the body) and HEADACHE (Headache). On 28-Mar-2021, the patient experienced PAIN (Stronger pain throughout my body), DYSPHONIA (Cold voice), DIARRHOEA (Loose stools), INFLUENZA LIKE ILLNESS (It's like I'm going to catch the flu) and HEADACHE (My head hurts too much). The patient was treated with ACETAMINOPHEN on 26-Mar-2021 at a dose of UNK dosage form. On 26-Mar-2021, DIZZINESS (Dizziness) had resolved. At the time of the report, DRY MOUTH (Dry mouth), DISCOMFORT (General discomfort in the body), PAIN (Stronger pain throughout my body), DYSPHONIA (Cold voice), DIARRHOEA (Loose stools), INFLUENZA LIKE ILLNESS (It's like I'm going to catch the flu), HEADACHE (Headache) and HEADACHE (My head hurts too much) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Dyspnoea, Headache, Oropharyngeal pain, Pain
Clinical narrative: low grade fever, achy, hard time breathing; low grade fever, achy, hard time breathing; low grade fever, achy, hard time breathing; headache, no taste, sore throat; headache, no taste, sore throat; headache, no taste, sore throat; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (low grade fever, achy, hard time breathing), DYSPNOEA (low grade fever, achy, hard time breathing), AGEUSIA (headache, no taste, sore throat), OROPHARYNGEAL PAIN (headache, no taste, sore throat) and HEADACHE (headache, no taste, sore throat) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced AGEUSIA (headache, no taste, sore throat), OROPHARYNGEAL PAIN (headache, no taste, sore throat) and HEADACHE (headache, no taste, sore throat). On 26-Mar-2021, the patient experienced PAIN (low grade fever, achy, hard time breathing), DYSPNOEA (low grade fever, achy, hard time breathing) and PYREXIA (low grade fever, achy, hard time breathing). At the time of the report, PAIN (low grade fever, achy, hard time breathing), DYSPNOEA (low grade fever, achy, hard time breathing), AGEUSIA (headache, no taste, sore throat), OROPHARYNGEAL PAIN (headache, no taste, sore throat), HEADACHE (headache, no taste, sore throat) and PYREXIA (low grade fever, achy, hard time breathing) had not resolved.            No treatment information was provided. Concomitant medication were not reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: low grade fever, achy, hard time breathing; low grade fever, achy, hard time breathing; low grade fever, achy, hard time breathing; headache, no taste, sore throat; headache, no taste, sore throat; headache, no taste, sore throat; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (low grade fever, achy, hard time breathing), DYSPNOEA (low grade fever, achy, hard time breathing), AGEUSIA (headache, no taste, sore throat), OROPHARYNGEAL PAIN (headache, no taste, sore throat) and HEADACHE (headache, no taste, sore throat) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced AGEUSIA (headache, no taste, sore throat), OROPHARYNGEAL PAIN (headache, no taste, sore throat) and HEADACHE (headache, no taste, sore throat). On 26-Mar-2021, the patient experienced PAIN (low grade fever, achy, hard time breathing), DYSPNOEA (low grade fever, achy, hard time breathing) and PYREXIA (low grade fever, achy, hard time breathing). At the time of the report, PAIN (low grade fever, achy, hard time breathing), DYSPNOEA (low grade fever, achy, hard time breathing), AGEUSIA (headache, no taste, sore throat), OROPHARYNGEAL PAIN (headache, no taste, sore throat), HEADACHE (headache, no taste, sore throat) and PYREXIA (low grade fever, achy, hard time breathing) had not resolved.            No treatment information was provided. Concomitant medication were not reported.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Hypoaesthesia, Myalgia, Pyrexia, Vomiting
Clinical narrative: Sweating; Numbness in the arm; Body aches; Throwing up; High fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), HYPOAESTHESIA (Numbness in the arm), MYALGIA (Body aches), VOMITING (Throwing up) and PYREXIA (High fever) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (Sweating), HYPOAESTHESIA (Numbness in the arm), MYALGIA (Body aches), VOMITING (Throwing up) and PYREXIA (High fever). At the time of the report, HYPERHIDROSIS (Sweating), HYPOAESTHESIA (Numbness in the arm), MYALGIA (Body aches), VOMITING (Throwing up) and PYREXIA (High fever) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Active case of shingles; This spontaneous case was reported by an other health care professional and describes the occurrence of HERPES ZOSTER (Active case of shingles) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Active case of shingles). At the time of the report, HERPES ZOSTER (Active case of shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: No specific follow-up information recorded. On 13-May-2021: No specific follow-up information recorded.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Skin irritation, Visual impairment
Clinical narrative: vision is still "iffy"; irritation; shingles on the forehead and around the eye; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (shingles on the forehead and around the eye), VISUAL IMPAIRMENT (vision is still "iffy") and SKIN IRRITATION (irritation) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No history provided by Reporter.  Concurrent medical conditions included Penicillin allergy, Drug allergy (sulfa drug allergy) and Drug allergy (Allergy to most of the pain medications). Concomitant products included SIMVASTATIN and LISINOPRIL for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced HERPES ZOSTER (shingles on the forehead and around the eye). On an unknown date, the patient experienced VISUAL IMPAIRMENT (vision is still "iffy") and SKIN IRRITATION (irritation). At the time of the report, HERPES ZOSTER (shingles on the forehead and around the eye) had not resolved and VISUAL IMPAIRMENT (vision is still "iffy") and SKIN IRRITATION (irritation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided by Reporter.   Reporter did not allow further contact.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: patient under 18 years of age, has been given the first dose of Moderna vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient under 18 years of age, has been given the first dose of Moderna vaccine) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient under 18 years of age, has been given the first dose of Moderna vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient under 18 years of age, has been given the first dose of Moderna vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age (17 year old female) for mRNA-1273 (lot number 040A21A) with no associated AEs reported.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site inflammation, Vaccination site pruritus, Vaccination site scar, Vaccination site swelling
Clinical narrative: swelling gets bigger; hard; swollen; big as a quarter; itchiness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INFLAMMATION (swelling gets bigger), VACCINATION SITE SCAR (hard), VACCINATION SITE PRURITUS (itchiness), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE INDURATION (big as a quarter) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN + HIDROCLOROTIAZIDA                                              for hypertension) for Hypertension, VITAMIN C [ASCORBIC ACID] (VITAMIN C [ASCORBIC ACID]                                                     for supplemental purposes) for Supplementation therapy.    On 18-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness). On 24-Mar-2021, the patient experienced VACCINATION SITE SCAR (hard), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE INDURATION (big as a quarter). On 25-Mar-2021, the patient experienced VACCINATION SITE INFLAMMATION (swelling gets bigger). At the time of the report, VACCINATION SITE INFLAMMATION (swelling gets bigger), VACCINATION SITE SCAR (hard), VACCINATION SITE PRURITUS (itchiness), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE INDURATION (big as a quarter) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment medication was provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Pain in extremity
Clinical narrative: Leg pain; Back Pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Leg pain) and BACK PAIN (Back Pain) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     Concurrent medical conditions included Leukemia, Lymphoma, Pancreatic cancer and Heart valve disorders.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (Leg pain) and BACK PAIN (Back Pain). At the time of the report, PAIN IN EXTREMITY (Leg pain) and BACK PAIN (Back Pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information included pain killers. No Concomitant medication were reported. Patient states that her Doctor warned her she would probably have pain due to her history of multiple Cancer.   This case was linked to MOD-2021-121825, MOD-2021-121825 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Additional information received on 11-MAY-2021 and does not contain any new information.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Pain
Clinical narrative: Weak; shoulder and arm pain/pain behind ear and back of neck; Very tired; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weak), PAIN (shoulder and arm pain/pain behind ear and back of neck) and FATIGUE (Very tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weak), PAIN (shoulder and arm pain/pain behind ear and back of neck) and FATIGUE (Very tired). The patient was treated with NAPROXEN for Pain, at an unspecified dose and frequency. At the time of the report, ASTHENIA (Weak) and FATIGUE (Very tired) outcome was unknown and PAIN (shoulder and arm pain/pain behind ear and back of neck) had resolved.            Symptom text:
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: White ring above the injection site about the size of a quarter; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (White ring above the injection site about the size of a quarter) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (White ring above the injection site about the size of a quarter). At the time of the report, VACCINATION SITE REACTION (White ring above the injection site about the size of a quarter) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No  concomitant medical  provided by the reporter. No treatment medication provided by the reporter.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Headache, Hyperhidrosis, Pain
Clinical narrative: Sweating; Dizzy; Diarrhea; Body hurt; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), DIZZINESS (Dizzy), DIARRHOEA (Diarrhea), PAIN (Body hurt) and PYREXIA (Fever) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced HYPERHIDROSIS (Sweating), DIZZINESS (Dizzy), DIARRHOEA (Diarrhea), PAIN (Body hurt), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, HYPERHIDROSIS (Sweating), DIZZINESS (Dizzy), DIARRHOEA (Diarrhea), PAIN (Body hurt), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included BC powder. No concomitant medications were reported.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Sweating; Dizzy; Diarrhea; Body hurt; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), DIZZINESS (Dizzy), DIARRHOEA (Diarrhea), PAIN (Body hurt) and PYREXIA (Fever) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced HYPERHIDROSIS (Sweating), DIZZINESS (Dizzy), DIARRHOEA (Diarrhea), PAIN (Body hurt), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, HYPERHIDROSIS (Sweating), DIZZINESS (Dizzy), DIARRHOEA (Diarrhea), PAIN (Body hurt), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included BC powder. No concomitant medications were reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Inflammation, Rash, Vaccination site inflammation
Clinical narrative: Redness in her upper arm; Inflamation in the injection area; Rash in her arm; Slight inflamation; This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (Slight inflamation), ERYTHEMA (Redness in her upper arm), VACCINATION SITE INFLAMMATION (Inflamation in the injection area) and RASH (Rash in her arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 18-Mar-2021, the patient experienced INFLAMMATION (Slight inflamation). On 26-Mar-2021, the patient experienced ERYTHEMA (Redness in her upper arm), VACCINATION SITE INFLAMMATION (Inflamation in the injection area) and RASH (Rash in her arm). At the time of the report, INFLAMMATION (Slight inflamation), ERYTHEMA (Redness in her upper arm), VACCINATION SITE INFLAMMATION (Inflamation in the injection area) and RASH (Rash in her arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Consent declined for follow up.
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives appeared as small clusters on the arms,torso and tops of the legs; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives appeared as small clusters on the arms,torso and tops of the legs) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced URTICARIA (Hives appeared as small clusters on the arms,torso and tops of the legs). On 26-Mar-2021, URTICARIA (Hives appeared as small clusters on the arms,torso and tops of the legs) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported No treatment medications were reported
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Poor quality product administered
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of out of specification product use (patient could have been provided a dose 6.5 hours after the vial was punctured) and pain in extremity (left arm sore after vaccination in the same arm) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# unknown) for COVID-19 immunization. The patient's past medical history included no adverse event. No medical history reported. On Mar 25, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. On Mar 25, 2021, patient experienced out of specification product use (patient could have been provided a dose 6.5 hours after the vial was punctured) and pain in extremity (left arm sore after vaccination in the same arm). On Mar 25, 2021, out of specification product use (patient could have been provided a dose 6.5 hours after the vial was punctured) resolved. At the time of the report, pain in extremity (left arm sore after vaccination in the same arm) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information provided. Reporter did not allow further contact.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Rash
Clinical narrative: had a rash at the injection side, pretty wide, warm and inflamed; had a rash on both arms where their elbow is, where the arm bends; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (had a rash at the injection side, pretty wide, warm and inflamed) and RASH (had a rash on both arms where their elbow is, where the arm bends) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     Concomitant products included ESTRADIOL (ESTROGEN) and PROGESTERONE for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced RASH (had a rash on both arms where their elbow is, where the arm bends). On 23-Mar-2021, the patient experienced INJECTION SITE RASH (had a rash at the injection side, pretty wide, warm and inflamed). The patient was treated with CLOBETASOL PROPIONATE (topical) for Allergic reaction, at an unspecified dose and frequency. At the time of the report, INJECTION SITE RASH (had a rash at the injection side, pretty wide, warm and inflamed) and RASH (had a rash on both arms where their elbow is, where the arm bends) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Wrong product administered
Clinical narrative: Patient received 1st dose of Johnson and Johnson vaccine/administered Moderna vaccine on his left arm as 2nd dose; Second dose administer after 15 days interval; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received 1st dose of Johnson and Johnson vaccine/administered Moderna vaccine on his left arm as 2nd dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose administer after 15 days interval) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.    Co-suspect product included non-company product COVID-19 VACCINE NRVV AD26 (GAM-COVID-VAC) for COVID-19 vaccination.    No Medical History information was reported.   On 26-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient received dose of COVID-19 VACCINE NRVV AD26 (GAM-COVID-VAC) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced WRONG PRODUCT ADMINISTERED (Patient received 1st dose of Johnson and Johnson vaccine/administered Moderna vaccine on his left arm as 2nd dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose administer after 15 days interval). On 26-Mar-2021, WRONG PRODUCT ADMINISTERED (Patient received 1st dose of Johnson and Johnson vaccine/administered Moderna vaccine on his left arm as 2nd dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose administer after 15 days interval) had resolved. Unknown      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment related information has been reported. Johnson and Johnson Covid-19 vaccine administered as first dose.; Sender's Comments: This refers to a case of wrong product administration and inappropriate schedule of product administration for mRNA 1273 (lot# 046A21A) with no associated AEs reported .
Sex: F
Vaccine: COVID19
Symptoms: Syringe issue, Underdose
Clinical narrative: she said she didn't receive the entire dose. Some of it dripped down her arm; she said she didn't receive the entire dose. Some of it dripped down her arm; A spontaneous report was received from a consumer concerning a female patient (age: unknown) who received Moderna's COVID-19 vaccine (mRNA-1273) and didn't receive the entire dose. Some of it dripped down her arm (underdose and syringe issue).  The patient's medical history was not provided. Concomitant medications reported were unknown.   On 26 MAR 2021, prior to the onset of the events the patient received her first of the two planned vaccine doses of mRNA-1273 (lot/batch : unknown) intramuscularly for prophylaxis of COVID-19 infection. The patient said that she didn't receive the entire dose. Some of it dripped down her arm and she wants to know how this will effect the efficacy of the entire dose.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.   The outcome of event didn't receive the entire dose, some of it dripped down her arm, was considered unknown.; Reporter's Comments: This report refers to a case of Underdose and syringe issue, for mRNA-1273, lot # unknown,  with no associated AEs.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Bone pain, Feeling abnormal, Neck pain, Nightmare, Pain
Clinical narrative: Bad nightmare, feels like someone beat the hell out of him, feels like he was kicked in the chest; Woke up on the floor out of his bed; Pain; Right collar bone hurts; Neck hurts; Feels like he was attacked in the middle of the night; Right arm hurts; This spontaneous case was reported by a consumer and describes the occurrence of NIGHTMARE (Bad nightmare, feels like someone beat the hell out of him, feels like he was kicked in the chest), SLEEP DISORDER (Woke up on the floor out of his bed), PAIN (Pain), BONE PAIN (Right collar bone hurts) and NECK PAIN (Neck hurts) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No adverse event history). Concomitant products included LORATADINE, ALBUTEROL SULFATE, OLODATEROL HYDROCHLORIDE, TIOTROPIUM BROMIDE MONOHYDRATE (STIOLTO RESPIMAT), COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), ASCORBIC ACID (VIT C), CALCIUM CARBONATE, FERROUS SULFATE, MALUS SPP., ZINC CITRATE, ZINC SULFATE (MULTIVIT [CALCIUM CARBONATE;FERROUS SULFATE;MALUS SPP.;ZINC CITRATE;ZINC SULFATE]) and OMEPRAZOLE for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced NIGHTMARE (Bad nightmare, feels like someone beat the hell out of him, feels like he was kicked in the chest), SLEEP DISORDER (Woke up on the floor out of his bed), PAIN (Pain), BONE PAIN (Right collar bone hurts), NECK PAIN (Neck hurts), FEELING ABNORMAL (Feels like he was attacked in the middle of the night) and PAIN IN EXTREMITY (Right arm hurts). At the time of the report, NIGHTMARE (Bad nightmare, feels like someone beat the hell out of him, feels like he was kicked in the chest), SLEEP DISORDER (Woke up on the floor out of his bed), PAIN (Pain), BONE PAIN (Right collar bone hurts), NECK PAIN (Neck hurts), FEELING ABNORMAL (Feels like he was attacked in the middle of the night) and PAIN IN EXTREMITY (Right arm hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Sleep disorder
Clinical narrative: Bad nightmare, feels like someone beat the hell out of him, feels like he was kicked in the chest; Woke up on the floor out of his bed; Pain; Right collar bone hurts; Neck hurts; Feels like he was attacked in the middle of the night; Right arm hurts; This spontaneous case was reported by a consumer and describes the occurrence of NIGHTMARE (Bad nightmare, feels like someone beat the hell out of him, feels like he was kicked in the chest), SLEEP DISORDER (Woke up on the floor out of his bed), PAIN (Pain), BONE PAIN (Right collar bone hurts) and NECK PAIN (Neck hurts) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No adverse event history). Concomitant products included LORATADINE, ALBUTEROL SULFATE, OLODATEROL HYDROCHLORIDE, TIOTROPIUM BROMIDE MONOHYDRATE (STIOLTO RESPIMAT), COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), ASCORBIC ACID (VIT C), CALCIUM CARBONATE, FERROUS SULFATE, MALUS SPP., ZINC CITRATE, ZINC SULFATE (MULTIVIT [CALCIUM CARBONATE;FERROUS SULFATE;MALUS SPP.;ZINC CITRATE;ZINC SULFATE]) and OMEPRAZOLE for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced NIGHTMARE (Bad nightmare, feels like someone beat the hell out of him, feels like he was kicked in the chest), SLEEP DISORDER (Woke up on the floor out of his bed), PAIN (Pain), BONE PAIN (Right collar bone hurts), NECK PAIN (Neck hurts), FEELING ABNORMAL (Feels like he was attacked in the middle of the night) and PAIN IN EXTREMITY (Right arm hurts). At the time of the report, NIGHTMARE (Bad nightmare, feels like someone beat the hell out of him, feels like he was kicked in the chest), SLEEP DISORDER (Woke up on the floor out of his bed), PAIN (Pain), BONE PAIN (Right collar bone hurts), NECK PAIN (Neck hurts), FEELING ABNORMAL (Feels like he was attacked in the middle of the night) and PAIN IN EXTREMITY (Right arm hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itching 180 degree opposed to the injection site / Itching is subcutaneous; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching 180 degree opposed to the injection site / Itching is subcutaneous) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     The patient's past medical history included Allergic reaction. Concomitant products included VITAMIN C [ASCORBIC ACID], COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching 180 degree opposed to the injection site / Itching is subcutaneous). At the time of the report, PRURITUS (Itching 180 degree opposed to the injection site / Itching is subcutaneous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient experienced itching at below the site of the injection and it spreads to the elbow area. Patient was currently itching between his arm within the ribcage region to the elbow, 180 opposed to where the injection was given on the same arm. Patient indicates that he has allergic reaction in the past but this experience does not look like allergic reaction and it is annoying. The itching was subcutaneous. This reaction occurs 99% of the time between 7pm upward.  Treatment details included Aloe Vera helps a little to relief the symptoms.